Observation Study of Sequential Regorafenib Plus ICIs After HAIC for Advanced Hepatocellular Carcinoma
NCT05573282
·
clinicaltrials.gov ↗
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
OTHER:
Regorafenib combine with ICIs
Sponsor
Sun Yat-sen University